DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-17 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claims 1-17 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, for containing the limitations “an ethoxylated C16-18 alcohol” and “an alkoxylated alcohol” in claim 1. These limitations render the claims vague and indefinite, since one of ordinary skill in the art would not be able to ascertain the metes and bounds of the limitation “an alkoxylated alcohol”. Does a composition that contains both a C16 and C18 ethoxylated alcohol meet the “alkoxylated alcohol” limitation? Does the “alkoxylated alcohol” have to be a compound that is not “an ethoxylated C16-18 alcohol”? Claims 2-17 are included in this rejection for being dependent upon claim 1. Appropriate correction and/or clarification is required.
Claim 2 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, for containing the limitations “wherein the polyoxyethylene-polyoxypropylene glycol has an average molecular weight of about 2090 to about 2360”. This limitation renders the claim vague and indefinite, since it is unclear if this refers to the “weight average molecular weight” or the “number average molecular weight” of the polyoxyethylene-polyoxypropylene glycol. Appropriate correction and/or clarification is required.
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure.
Bui et al, WO 2020/096890, discloses a composition for removing biological material from a medical device.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRIAN P MRUK whose telephone number is (571)272-1321. The examiner can normally be reached on 7:00am-5:30pm Monday-Thursday.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew, can be reached on 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/BRIAN P MRUK/
Primary Examiner, Art Unit 1761
Brian P Mruk
December 24, 2025
Prosecution Insights